Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03630731
What this trial is testing

Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Chinese Academy of Medical Sciences 32
Testing effectiveness (Phase 2)Study completedNCT03349502
What this trial is testing

MG4101 for Refractory or Relapsed AML

Who this might be right for
Acute Myeloid Leukemia
Seoul National University Hospital 11
Testing effectiveness (Phase 2)Looking for participantsNCT07480213
What this trial is testing

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCSCLC, Extensive Stage
Beijing Biotech 60
Not applicableLooking for participantsNCT05859191
What this trial is testing

Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus

Who this might be right for
Systemic Lupus ErythematosusPhysiopathology
University Hospital, Tours 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783478
What this trial is testing

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

Who this might be right for
Acute Myeloid Leukaemia (AML)
Hospital de Clinicas de Porto Alegre 98
Testing effectiveness (Phase 2)Study completedNCT00352235
What this trial is testing

Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 36
Early research (Phase 1)Study completedNCT00631072
What this trial is testing

In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer

Who this might be right for
Malignant Melanoma
Beth Israel Deaconess Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT00145626
What this trial is testing

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplasia+2 more
St. Jude Children's Research Hospital 40
Not applicableStudy completedNCT02887599
What this trial is testing

Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities

Who this might be right for
Pancreatic Cancer
Yonsei University 203
Testing effectiveness (Phase 2)Ended earlyNCT00698009
What this trial is testing

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT03051555
What this trial is testing

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Peking University Cancer Hospital & Institute 60
Not applicableStudy completedNCT03779399
What this trial is testing

Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor

Who this might be right for
Ovarian CancerBorderline Ovarian TumorsBenign Ovarian Tumor+1 more
Medical University of Lublin 60
Testing effectiveness (Phase 2)Study completedNCT01823198
What this trial is testing

Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Erythroid LeukemiaAcute Megakaryoblastic Leukemia+12 more
M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT01007526
What this trial is testing

Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma

Who this might be right for
NK/T-cell Lymphoma of Nasal Cavity
Samsung Medical Center 31
Not applicableStudy completedNCT02895204
What this trial is testing

Effect of Fermented Maillard Reacted Whey Protein on Immune Function

Who this might be right for
Immune Deficiency
Yonsei University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02491697
What this trial is testing

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer

Who this might be right for
Breast Cancer
The First People's Hospital of Changzhou 400
Testing effectiveness (Phase 2)Looking for participantsNCT06853223
What this trial is testing

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Who this might be right for
Primary Graft DysfunctionLung TransplantationAcute Lung Injury(ALI)+1 more
University of California, San Francisco 120
Early research (Phase 1)Study completedNCT00720785
What this trial is testing

Natural Killer Cells and Bortezomib to Treat Cancer

Who this might be right for
Chronic Myeloid Leukemia (CML)Pancreatic CaColon/Rectal Ca+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)UnknownNCT01839539
What this trial is testing

Study of DC-CIK to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Guangxi Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06733935
What this trial is testing

NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Who this might be right for
Systemic SclerosisIdiopathic Inflammatory MyopathiesAntineutrophil Cytoplasmic Antibody-Associated Vasculitis+1 more
Nkarta, Inc. 240
Next Page